Category Archives for Chart of the day
Extreme Option Profits Chart of the Day…Luminar Technologies (LAZR)
Keep an eye on Luminar Technologies (LAZR). After bottoming out around $14, LAZR is just starting to pivot higher. From a current price of $17.44, we’d like to see the stock test its prior high around $24 with solid catalysts. One, the company just increased its buyback program to $300 million worth of stock. Two, Citi […]
Continue readingExtreme Option Profits Chart of the Day…General Motors (GM)
General Motors just agreed to a strategic collaboration with MP Materials. According to CNBC, “MP Materials owns and runs the Mountain Pass rare earth mine, located in California near the Mojave National Preserve. Under the deal with GM, MP Materials will supply the Detroit automaker with rare earth materials, alloy and finished magnets that will […]
Continue readingExtreme Option Profits Chart of the Day…Apple (AAPL)
Apple has been on fire this year. After opening at $130.70 in January, the tech stock is now up to $170.60 – and could see $200, near-term. That’s according to Morgan Stanley’s Katy Huberty, who just raised her price target from $164 to $200 a share. All on the belief new products like augmented reality, and a […]
Continue readingExtreme Option Profits Chart of the Day…Li Auto (LI)
Electric vehicle stocks, like Li Auto (LI) could be some of the biggest winners of 2022. Just this week, Li Auto reported adjusted EPS of three cents a share on $1.21 billion in sales. The Street was looking for a three-cent loss on $1.13 billion in sales. “In light of our strong order intake and users’ rising […]
Continue readingExtreme Option Profits Chart of the Day…Riot Blockchain (RIOT)
One of the top stocks to consider on the latest pullback is Riot Blockchain (RIOT). One of the biggest moneymakers of 2021 has been Bitcoin. After starting the year at $28,784, the digital currency rallied to a high of $68,978. While it recently pulled back to $57,680, chances are good it could see higher highs. According to Fundstrat […]
Continue readingExtreme Option Profits Chart of the Day…Cassava Sciences (SAVA)
Keep an eye on Cassava Sciences (SAVA). For the second time, Cassava Sciences (SAVA) took a hit on allegations of wrongdoing. In fact, over the last week, shareholder firm Labaton Sucharow claims the “scientific experiments backing Cassava’s drug, simufilam, are impossible and the biomarker discrepancies ‘are so extreme they suggest lab errors or manipulation.’ Further, the firm […]
Continue readingExtreme Option Profits Chart of the Day…Meta Platforms (FB)
Keep an eye on the Meta Platforms (FB). For one, the stock is quickly rebounding from oversold conditions. If it can break above its 50-day moving average around $340.89, FB could potentially re-test highs around $380. Two, FB is gaining momentum from the metaverse story, as it invests about $10 billion in its development. Even more exciting, we […]
Continue readingExtreme Option Profits Chart of the Day…PayPal (PYPL)
Keep an eye on the PayPal (PYPL) pullback. After racing from a low of $87 in early 2020 to a high of $309.48, the stock fell to a recent low of $204.58. All thanks to its consumer spending concerns, and poor 2022 guidance. For example, the company said fiscal 2022 revenue would increase about 18%, which would […]
Continue readingExtreme Option Profits Chart of the Day…US Steel (X)
Keep an eye on steel stocks like US Steel (X) and Steel Dynamics (STLD). With Congress passing the Infrastructure Investment and Jobs Act, which invests in roads, railways, bridges, and broadband, steel stocks could be some of the biggest winners. According to NPR, the bill includes money for: Roads, bridges, major projects: $110 billion, Passenger and freight […]
Continue readingExtreme Option Profits Chart of the Day…Teva Pharmaceuticals (TEVA)
Keep an eye on Teva Pharmaceuticals (TEVA). It’s just one of many pharmaceutical stocks pushing higher on a court decision in a $50 billion opioid lawsuit. Orange County Superior Court Judge Peter Wilson issued a tentative ruling in favor of the drug makers in a $50 billion opioid case. The original suit accused the companies of causing […]
Continue reading